Back to Market Feed

FONDAPARINUX 5 MG/0.4 ML SYR

Fondaparinux Sodium
$55.3125per ML

Strength

5 mg/.4mL

NDC

55111067910

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

9/17/2025

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA091316

On Market Since

7/14/2011

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

1 alternative • Same active ingredient

FONDAPARINUX 5 MG/0.4 ML SYR
Generic
00781345495•Sandoz Inc.
$55.3125

Related Drugs

Same classification

RIVAROXABAN 2.5 MG TABLET
Generic
33342048809•Macleods Pharmaceuticals Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
33342048857•Macleods Pharmaceuticals Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
43598098118•Dr. Reddy's Laboratories Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
43598098160•Dr. Reddy's Laboratories Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
50228051318•ScieGen Pharmaceuticals Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
50228051360•ScieGen Pharmaceuticals Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
51672422804•Sun Pharmaceutical Industries Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
51672422809•Sun Pharmaceutical Industries Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
59651084918•Aurobindo Pharma Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
59651084960•Aurobindo Pharma Limited
$0.9559
per EA